The Associated Press @AP
The FDA is granting fewer accelerated approvals and pushing more drugmakers to remove unproven uses from their medicines. The tougher stance comes as accelerated approval faces new scrutiny. https://t.co/O5IiKqgqTA — PolitiTweet.org